1. Home
  2. MSDL vs DRRX Comparison

MSDL vs DRRX Comparison

Compare MSDL & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSDL
  • DRRX
  • Stock Information
  • Founded
  • MSDL 2019
  • DRRX 1998
  • Country
  • MSDL United States
  • DRRX United States
  • Employees
  • MSDL N/A
  • DRRX N/A
  • Industry
  • MSDL
  • DRRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSDL
  • DRRX Health Care
  • Exchange
  • MSDL NYSE
  • DRRX Nasdaq
  • Market Cap
  • MSDL 1.7B
  • DRRX N/A
  • IPO Year
  • MSDL N/A
  • DRRX 2000
  • Fundamental
  • Price
  • MSDL $19.25
  • DRRX $0.61
  • Analyst Decision
  • MSDL Hold
  • DRRX Hold
  • Analyst Count
  • MSDL 5
  • DRRX 1
  • Target Price
  • MSDL $20.00
  • DRRX N/A
  • AVG Volume (30 Days)
  • MSDL 431.0K
  • DRRX 47.0K
  • Earning Date
  • MSDL 01-01-0001
  • DRRX 08-12-2025
  • Dividend Yield
  • MSDL 11.43%
  • DRRX N/A
  • EPS Growth
  • MSDL N/A
  • DRRX N/A
  • EPS
  • MSDL N/A
  • DRRX N/A
  • Revenue
  • MSDL N/A
  • DRRX $1,856,000.00
  • Revenue This Year
  • MSDL $1,597.39
  • DRRX N/A
  • Revenue Next Year
  • MSDL $15.10
  • DRRX $673.00
  • P/E Ratio
  • MSDL N/A
  • DRRX N/A
  • Revenue Growth
  • MSDL N/A
  • DRRX 79.84
  • 52 Week Low
  • MSDL $17.59
  • DRRX $0.48
  • 52 Week High
  • MSDL $23.63
  • DRRX $1.74
  • Technical
  • Relative Strength Index (RSI)
  • MSDL 50.38
  • DRRX 46.88
  • Support Level
  • MSDL $18.84
  • DRRX $0.57
  • Resistance Level
  • MSDL $19.19
  • DRRX $0.69
  • Average True Range (ATR)
  • MSDL 0.28
  • DRRX 0.06
  • MACD
  • MSDL 0.02
  • DRRX -0.00
  • Stochastic Oscillator
  • MSDL 75.95
  • DRRX 48.12

About MSDL MORGAN STANLEY DIRECT LENDING FUND

Morgan Stanley Direct Lending Fund is a fund whose investment objective is to achieve attractive risk-adjusted returns via current income and to a lesser extent, capital appreciation by investing predominantly in directly originated senior secured term loans issued by U.S. middle-market companies backed by private equity sponsors. It invests predominantly in directly originated senior secured term loans including first lien senior secured term loans including unitranche loans and second lien senior secured term loans, with the balance of the investments expected to be in higher-yielding assets such as mezzanine debt, unsecured debt, equity investments and other opportunistic asset purchases.

Share on Social Networks: